Improving beliefs about medication in patients with Rheumatoid Arthritis: randomised controlled study into the effect of a motivational patient-centered intervention for non-adherent patients compared to usual care controls

Improving beliefs about medication in patients with Rheumatoid Arthritis: randomised controlled study into the effect of a motivational patient-centered intervention for non-adherent patients compared to usual care controls - Improving beliefs about medication in patients with Rheumatoid Arthritis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33599

Enrollment

120

Registered

2009-05-29

Start date

2009-09-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reumatische ziekten rheumatic ailment Rheumatoid arthritis

Interventions

The experimental group will receive a motivational patient-centered intervention aimed at the participants personal barrier(s). The intervention includes two group sessions of 90 minutes each and a

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -RA according to the 1986 ARA criteria for at least 1 year -Prescription of anti-rheumatic medication (DMARDs) -Non-adherent (less than 80% adherence) assessed with the Compliance Questionnaire Rheumatology

Exclusion criteria

Exclusion criteria: -Co-morbidity (physical or psychological) that unables the patient to participate in the intervention -Illiteracy -Inability to communicate in Dutch -Younger than 18 years -Participation in focusgroups June 2008 -Participation in other studies with significant patient burden

Design outcomes

Primary

Measure	Time frame
Beliefs about medication: -Beliefs about Medicines Questionnaire (BMQ)	—

Secondary

Measure	Time frame
-Adherence: Refill rates, Medication Adherence Report Scale (MARS) and Compliance Questionnaire Rheumatology (CQR) -Statisfaction with information about medication: Satisfaction with Information about Medicines Scale (SIMS) -Physical functioning: Health Assessment Questionnaire (HAQ) -Disease activity: Disease Activity Score (DAS28) -Pain: Visual Analoge Scale (VAS) Pain -Self-efficacy: UitvoerbaarheidsVerwachting bij het omgaan met de gevolgen van Reuma -Self-efficacy: Self-Efficacy Scale Medication Adherence DMARDs -Mood: Hospital Anxiety and Depression Scale (HADS) -Illness cognitions: Illness Perception Questionnaire (ICQ) -Acceptance of and anxiety for medicatie: Acceptance of Medication and Anxiety about Medication Scale DMARDs -Concordance: Besluitvorming Patiënt -Patient provider shared concerns: Patient Provider Shared Concerns -Experienced adverse effects and health care utilisation: patient registration card (every month)	—

Measure

Time frame

-Adherence: Refill rates, Medication Adherence Report Scale (MARS) and Compliance Questionnaire Rheumatology (CQR) -Statisfaction with information about medication: Satisfaction with Information about Medicines Scale (SIMS) -Physical functioning: Health Assessment Questionnaire (HAQ) -Disease activity: Disease Activity Score (DAS28) -Pain: Visual Analoge Scale (VAS) Pain -Self-efficacy: UitvoerbaarheidsVerwachting bij het omgaan met de gevolgen van Reuma -Self-efficacy: Self-Efficacy Scale Medication Adherence DMARDs -Mood: Hospital Anxiety and Depression Scale (HADS) -Illness cognitions: Illness Perception Questionnaire (ICQ) -Acceptance of and anxiety for medicatie: Acceptance of Medication and Anxiety about Medication Scale DMARDs -Concordance: Besluitvorming Patiënt -Patient provider shared concerns: Patient Provider Shared Concerns -Experienced adverse effects and health care utilisation: patient registration card (every month)

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)